Systemic Bioactivity of Inhaled Nebulized RNS60
Clinical trial NCT02490865 · COMPLETED
Trial details
- NCT number
- NCT02490865
- Sponsor
- Revalesio Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2015-08-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.